Loveček Martin, Skalický Pavel, Urban Ondřej, Tesaříková Jana, Kliment Martin, Psár Róbert, Švébišová Hana, Urban Kateřina, Mohelníková-Duchoňová Beatrice, Klos Dušan, Stašek Martin
Department of Surgery I, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic.
Department of Internal Medicine II-Gastroentrology and Geriatrics, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic.
Biomedicines. 2022 Jun 12;10(6):1392. doi: 10.3390/biomedicines10061392.
Endosonography-guided fine needle aspiration biopsy (EUS-FNA)-associated metachronous gastric seeding metastases (GSM) of pancreatic ductal adenocarcinoma (PDAC) represent a serious condition with insufficient evidence.
Retrospective analysis of PDAC resections with a curative-intent, proven pathological diagnosis of PDAC, preoperative EUS-FNA and post-resection follow-up of at least 60 months. The systematic literature search of published data was used for the GSM growth evaluation using Pearson correlation and the linear regression analyses.
The inclusion criteria met 59/134 cases, 16 (27%) had retained needle tract (15 following distal pancreatectomy, 1 following pylorus-sparing head resection). In total, 3/16 cases (19%) developed identical solitary GSM (10-26th month following primary surgery) and were radically resected. A total of 30 published cases of PDAC GSM following EUS-FNA were identified. Lesion was resected in 20 distal pancreatectomy cases with complete information in 14 cases. A correlation between the metastasis size and time (r = 0.612) was proven. The regression coefficient b = 0.72 expresses the growth of 0.72 mm per month.
The GSM represent a preventable and curable condition. A remarkably high number of GSM following EUS-FNA was identified, leading to follow-up recommendation of EUS-FNA sampled patients. Multimodal management (gastric resection, adjuvant chemotherapy) may prolong survival.
超声内镜引导下细针穿刺活检(EUS-FNA)相关的胰腺导管腺癌(PDAC)异时性胃种植转移(GSM)是一种证据不足的严重情况。
对具有治愈意图、经病理证实为PDAC的PDAC切除术、术前EUS-FNA及术后至少60个月的随访进行回顾性分析。使用Pearson相关性和线性回归分析对已发表数据进行系统文献检索,以评估GSM的生长情况。
纳入标准符合59/134例,16例(27%)有针道残留(15例在胰体尾切除术后,1例在保留幽门的胰头切除术后)。总共3/16例(19%)发生了相同的孤立性GSM(初次手术后10-26个月)并接受了根治性切除。总共确定了30例EUS-FNA后发生PDAC GSM的已发表病例。20例胰体尾切除病例中病变被切除,14例有完整信息。证实转移灶大小与时间之间存在相关性(r = 0.612)。回归系数b = 0.72表示每月生长0.72毫米。
GSM是一种可预防和可治愈的情况。EUS-FNA后发现大量GSM,因此建议对接受EUS-FNA采样的患者进行随访。多模式管理(胃切除、辅助化疗)可能延长生存期。